Clinical Trial Update: Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma [NA]

View source ↗

Summary

This clinical trial registry entry describes a study applying stem cell analysis, multi-omics, and artificial intelligence to glioblastoma (IDH-wildtype) and no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Glioblastoma, IDH-wildtype | NA | Status: RECRUITING